Curium SAS, a leading player in the nuclear medicine industry, is headquartered in France and operates extensively across Europe and North America. Founded in 2017, the company has quickly established itself as a key provider of radiopharmaceuticals, focusing on innovative solutions for cancer diagnosis and treatment. Curium's core offerings include a range of diagnostic imaging agents and therapeutic products, distinguished by their high quality and reliability. The company is committed to advancing patient care through its cutting-edge technologies and extensive expertise in the field. With a strong market position, Curium SAS has achieved significant milestones, including the integration of several prominent radiopharmaceutical businesses, enhancing its portfolio and global reach. As a trusted partner in healthcare, Curium continues to lead the way in the development of life-saving nuclear medicine solutions.
How does Curium SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Curium SAS's score of 14 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Curium SAS, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Curium SAS may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and engaging in initiatives to mitigate climate change. However, without specific emissions data or commitments, it is challenging to assess Curium SAS's position relative to its peers in terms of sustainability and climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Curium SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
